Exam 3- Lec 29 Parkinson Flashcards
Classification of Parkinson’s
- idiopathic
- iatrogenic: drug induced, particularly by antipsychotics
- post-traumatic, post encephalitic, atherosclerotic
What was observed in the brain with people with Parkinson’s disease?
Parkinson’s patients brain is missing Substantia Nigra- that produces dopamine as neurotransmitter
drugs that enhance dopaminergic activity
- L-DOPA
- selgiline/deprenyl
- entacopone
drugs that reduce cholinergic activity
Benztropine
Trihexiphenidyl
diphenhydramine
l-DOPA
- enhances dopaminergic activity
- dopamine precursor: converted to dopamine
- most effective drug for control of symptoms
- Do not give it to pts with cardiovascular disease
l-dopa pharmacokinetics
- well absorbed from GI tract
- enters brain by active transport AA pump
- metabolized to form dopamine by DOPA decarboxylase: brain and periphery
Selegiline/deprenyl
inhibits the metabolism of dopamine by MAO-B
MAO-B inhibitor
Entacapone
inhibits COMT and slows the metabolism of dopamine
Bromocryptine
Stimulate post-synaptic dopamine receptor
Pergolide and pramipexole - dopamine agonist
Bentropine and trihexyphenidyl
- reduce cholinergic activity
- block muscarinic receptor
Diphenhydramine
number one drug/ only drug used in emergency treatment of drug induced Parkinson’s
- block muscarinic receptors
Clozapine
treatment of schizophrenia
manages psychiatric side effects of I-DOPA
Extrapyramidal motor symptoms
choreiform movements: after long term therapy or when used with carbidopa
*Dopamine activity outweighs ACH activity
Endocrine effects of I-DOPA
acts to inhibit prolactin secretion
behavioral effects l-DOPA
depression
psychotic reactions
nightmares
euphoria
mood and personality changes